This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wollina, U. Articles by Pramatarov, K. Search for Related Content PubMed PubMed Citation Articles by Wollina, U. Articles by Pramatarov, K. Social Bookmarking                         What's this?

Disabling Pansclerotic Morphea of Childhood Poses a High Risk of Chronic Ulceration of the Skin and Squamous Cell Carcinoma

Department of Dermatology and Allergology, wollina-uw{at}khdf.de

Michael Buslau

Kantonsspital Schaffhausen, Switzerland

Birgit Heinig

Department of Physical Therapy

Ivailo Petrov

Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria

Eleonore Unger

Department of Internal Medicine I/Rheumatology

Eugenia Kyriopoulou

Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria

André Koch

Department of Dermatology and Allergology

Erich Köstler

Department of Dermatology and Allergology

Jaqueline Schönlebe

Institute of Pathology "Georg Schmorl," Hospital Dresden-Friedrichstadt, Dresden, Germany

Gunther Haroske

Institute of Pathology "Georg Schmorl," Hospital Dresden-Friedrichstadt, Dresden, Germany

Thorsten Doede

Department of Pediatric Surgery, Medical School-Freidrich Schiller University of Jena, Jena, Germany

Kyrill Pramatarov

Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria

Disabling pansclerotic morphea of childhood (DPMC) is a rare and severe variant of scleroderma. This report presents 3 cases that presented to the authors and studies 25 patients from the literature (English language only) for the presence of chronic nonhealing ulcers of skin and skin cancer. The authors identified a total of 30 patients (9 male and 21 female) aged between 1 and 37 years at time of presentation. All cases were less than 14 years old when the disease started. The majority of patients had an aggressive course with deep sclerotic lesions leading to joint contractures and immobility. Five patients suffered from chronic nonhealing leg ulcers (17%), but ulcers were present on other parts of the body (upper limbs, trunk, head) as well (n = 6). Four patients died because of complications of the disease such as sepsis or gangrene. Two patients developed a squamous cell carcinoma at the age of 16 years and 19 years, respectively (6.7%). The available treatment of DMPC-associated ulcers is unsatisfying. Only temporary improvements have been seen in a minority of patients. We report on marked improvement of chronic leg ulcers by a combination of sildenafil 3 x 20 mg/day and repeated application of a porcine small intestinal submucosal acellular matrix.

Key Words: deep morphoea • disabling pansclerotic morphoea of childhood • chronic (leg) ulcers • squamous cell carcinoma • sildenafil • tissue-engineered skin substitutes

References

• Black CM Scleroderma and fasciitis in children. Curr Opin Rheumatol 1995;7:442-8.[Medline] [Order article via Infotrieve]
• Zulina F., Athreya BH, Laxer R., Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology 2006;45:614-20.
• Chung L., Lin J., Furst DE, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol 2006;24:374-92.[CrossRef][Medline] [Order article via Infotrieve]
• Diaz-Perez JL, Connolly SM, Winkelmann RK Disabling pansclerotic morphea of children. Arch Dermatol 1980;116:169-73.[Abstract/Free Full Text]
• Wollina U., Heinig B., Uhlemann C. Transdermal CO2 application in chronic wounds. Int J Lower Extremity Wounds 2004; 3:103-6.[CrossRef]
• Tausche A-K., Skaria M., Böhlen L., Liebold K., Hafner J., Friedlein H., et al. An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Rep Reg 2003;11:248-52.[CrossRef]
• Wollina U., Looks A., Uhlemann C., Wollina K. Pansclerotic morphoea of childhood—follow-up over 6 years. Pediatr Dermatol 1999;16:245-7.[CrossRef][Medline] [Order article via Infotrieve]
• Rowell NR Acral pansclerotic morphea with intractable pain. In: Wilkinson DS, Mascaró JM, Orfanos CE, editors. Clinical dermatology—the CMD case collection. Stuttgart: Schattauer; 1987. p. 178-80.
• Hafner J., Truëb RM Management of leg ulcers in rheumatoid arthritis and systemic sclerosis. Curr Probl Dermatol 1999;27:271-6.[Medline] [Order article via Infotrieve]
• Fries R., Shariat K., von Wilmowsky H., Böhm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 2005;112:2980-5.[Abstract/Free Full Text]
• Yung A., Reay N., Goodfield MD Improvement in digital flexibility and dexterity following ingestion of sildenafil citrate (viagra) in limited systemic sclerosis. Arch Dermatol 2005;141:831-3.[Free Full Text]
• Cavorsi J., Vicari F., Wirthlin DJ, Ennis W., Kirsner R., O'Connell SM, et al. Best-practise algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Reg 2006;14:102-9.[CrossRef]
• Bello YM, Falabella AF, Eaglstein WH Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001;2:305-13.[CrossRef][Medline] [Order article via Infotrieve]
• Mostow EN, Haraway GD, Dalsing M., Hodde JP, King D., OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005;41:837-43.[CrossRef][Medline] [Order article via Infotrieve]
• Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 2005; 18:258-66.[Medline] [Order article via Infotrieve]
• Romanelli M., Dini V., Bertone M., Barbanera S., Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 2007;4:3-7.[CrossRef][Medline] [Order article via Infotrieve]
• Wollina U. Increased risk of cancer in scleroderma: no risk in patients with morphoea? Ann Rheum Dis 2003;62:611-2.[Abstract/Free Full Text]
• Levi F., Moeckli R., Randimbison L., Te VC, Maspoli M., La Vecchia C. Skin cancer in survivors of childhood and adolescent cancer. Eur J Cancer 2006;42:656-9.[CrossRef][Medline] [Order article via Infotrieve]
• Pearce MS, Parker L., Cotterill SJ, Gordon PM, Craft AW Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK. Melanoma Res 2003;13:421-6.[CrossRef][Medline] [Order article via Infotrieve]
• Serafini P., Meckel K., Kelso M., Noonan K., Califano J., Koch W., et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 2006;27:2691-702.
• Ferrandiz C., Henkes J., González J., Peyri J. Incapacitating pansclerotic morphea in childhood. Med Cutan Ibero Lat Am 1981;9: 377-82.[Medline] [Order article via Infotrieve]
• Scharfetter-Kochanek K., Goldermann R., Lehmann P., Hölzle E., Goerz G. PUVA therapy in disabling morphoea of children. Br J Dermatol 1995;132:830-1.[CrossRef][Medline] [Order article via Infotrieve]
• Todd DJ, Askari A., Ektaisch E. PUVA therapy for disabling pansclerotic morphoea of children. Br J Dermatol 1998;138:201-2.[CrossRef][Medline] [Order article via Infotrieve]
• Stücker M., Schreiber D., Gruss C., Freitag M., von Kobyletzki G., Kerscher M., et al. Schwerer Verlauf einer pansklerotischen zirkumskripten Sklerodermie im Kindesalter. Klinik und Therapie. Hautarzt 1999;50:131-5.
• Nguyen XH, Hansen R., Valencia F. Severe ankle deformity secondary to pansclerotic morphea in a 9-year-old girl: correction involving arthrodesis and free flap coverage. Pediatr Dermatol 2002;19:560-3.[CrossRef][Medline] [Order article via Infotrieve]
• Nagai Y., Hattori T., Ishikawa O. Unilateral generalized morphea in childhood. J Dermatol 2002;29:435-8.[Medline] [Order article via Infotrieve]
• Singh DS, Kumar L., Radotra BD Disabling morphea of childhood and hypogammaglobulinemia: a curios association. Rheumatol Int 2002;21:158-60.[CrossRef][Medline] [Order article via Infotrieve]
• Yildirim M., Baysal V., Aridogan BC, Kesici D., Erturan I. Pansclerotic morphea treated with UVA: a case report. J Dermatol 2003;30:625-7.[Medline] [Order article via Infotrieve]
• Kawashima H., Watanabe C., Kashiwagi Y., Sato S., Ioi H., Sasamoto M., et al. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases. Pediatr Int 2006;48:342-8.[CrossRef][Medline] [Order article via Infotrieve]
• Roldan R., Morote G., Castro M del C, Miranda MD, Moreno JC, Collantes E. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling morphea in children. J Rheumatol 2006;33:2538-40.[Abstract/Free Full Text]

The International Journal of Lower Extremity Wounds, Vol. 6, No. 4, 291-298 (2007)
DOI: 10.1177/1534734607308731


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wollina, U. Articles by Pramatarov, K. Search for Related Content PubMed PubMed Citation Articles by Wollina, U. Articles by Pramatarov, K. Social Bookmarking                         What's this?